Diabetes, fibrinogen, and risk of cardiovascular disease: The Framingham experience
- 作者William B. Kannel; Ralph B. D'Agostino; Peter W.F. Wilson; Albert J. Belanger; David R. Gagnon
- 卷第120卷
- 期第3期
- 印刷ISSN0002-8703
- 电子ISSN1097-6744
- 文件大小537.65KB
- 发表时间1990
- DOI10.1016/0002-8703(90)90026-t
同标题推荐
Pharmacological evidence for a role of lipoxygenase products in platelet-activating factor (PAF)-induced hyperalgesiaAimee Dallob; Yvan Guindon; Marvin M. Goldenberg · 1987
Pharmacological evidence of a role for platelet activating factor as a modulator of vasomotor tone and blood pressureRodrigo Lopes-Martins; Marcelo Catelli; Cláudia Araújo; Vanessa Estato; Renato Cordeiro; Eduardo Tibiriçá · 1996
Platelet-activating Factor-induced Human Eosinophil Transendothelial Migration: Evidence for a Dynamic Role of the EndotheliumCasale, Thomas B.; Erger, Rochelle A.; Little, Marta M. · American Journal of Respiratory Cell and Molecular Biology · 1993